Target intelligence / Profile preview

microRNA 4642 (MIR4642)

Target
MIR4642
Molecular classification
microRNA, Non-coding RNA
01

Overview

microRNA 4642 (MIR4642) is a small non-coding RNA molecule classified as a microRNA within the human genome. MicroRNAs are ~22 nucleotides long and regulate gene expression post-transcriptionally by binding to partially complementary sequences on target messenger RNAs, leading to translational repression or mRNA degradation[2][4][5]. The biogenesis of microRNAs involves processing by Drosha and Dicer enzymes, after which the mature miRNA is loaded into the Argonaute (AGO) protein, forming part of the RISC silencing complex[2][4]. While the roles of many microRNAs in development, cancer, apoptosis, and differentiation are established[3][5], there are no specific biological functions, disease associations, or therapeutic targeting described for MIR4642 as of the current literature. MIR4642 may be expressed in various cells and tissues, but detailed functional and pathological roles require further study.

Other names
hsa-mir-4642MIR4642microRNA 4642
02

Mechanism of action

Not applicable. No drugs are known to target MIR4642 directly. Generally, microRNAs mediate gene silencing via RNA-induced silencing complex (RISC) loading and mRNA binding[2][4][5].

03

Biological functions

Gene regulation (post-transcriptional gene silencing)RNA interferencemRNA degradation and destabilizationSuppression of mRNA translation
04

Disease associations

Other (In general, microRNAs can be involved in cancer, cell differentiation, apoptosis, and other diseases, but there is no disease specifically linked to microRNA 4642 in the current literature)
05

Safety considerations

None specifically identified for MIR4642. General challenges in targeting microRNAs include specificity, off-target effects, and delivery.

Beyond the preview

Go deeper on microRNA 4642 (MIR4642).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 4642 (MIR4642).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call